Novavax Inc vs Williams-Sonoma, Inc. — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Williams-Sonoma, Inc. trades at $223.2 (market cap $26.30B). The key difference: Williams-Sonoma, Inc. is far larger — about 20.2× Novavax Inc's market cap, and Williams-Sonoma, Inc. pays a 1.36% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | WSM | |
|---|---|---|
Market Cap | $1.30B | $26.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $240.06 |
52-Week Low | $6.22 | $168.64 |
Enterprise Value | $800.50M | $27.14B |
Dividend Yield | — | 1.36% |
Trailing returns across standard periods
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →